|
1
|
Allum WH, Stenning SP, Bancewicz J, Clark
PI and Langley RE: Long-term results of a randomized trial of
surgery with or without preoperative chemotherapy in esophageal
cancer. J Clin Oncol. 27:5062–5067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographicregions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paterlini-Brechot P and Benali NL:
Circulating tumor cells (CTC) detection: Clinical impact and future
directions. Cancer Lett. 253:180–204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
et al: Circulating tumor cells: A novel prognostic factor for newly
diagnosed metastatic breast cancer. J Clin Oncol. 23:1420–1430.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sabile A, Louha M, Bonte E, Poussin K,
Vona G, Mejean A, Chretien Y, Bougas L, Lacour B, Capron F, et al:
Efficiency of Ber-EP4 antibody in isolating circulating epithelial
tumor cells before RT-PCR detection. Am J Clin Pathol. 112:171–178.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells: A new method for
the immunomorphological and molecular characterization of
circulating tumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anker P, Mulcahy H and Stroun M:
Circulating nucleic acids in plasma and serum as a noninvasive
investigation for cancer: Time for large-scale clinical studies?
Int J Cancer. 103:149–152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clarke LE, Leitzel K, Smith J, Ali SM and
Lipton A: Epidermal growth factor receptor mRNA in peripheral blood
of patients with pancreatic, lung, and colon carcinomas detected by
RT-PCR. Int J Oncol. 22:425–430. 2003.PubMed/NCBI
|
|
13
|
Chen TF, Jiang GL, Fu XL, Wang LJ, Qian H,
Wu KL and Zhao S: CK19 mRNA expression measured by
reverse-transcription polymerase chain reaction (RT-PCR) in the
peripheral blood of patients with non-small cell lung cancer
treated by chemo-radiation: An independent prognostic factor. Lung
Cancer. 56:105–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo J, Xiao B, Jin Z, Qin L, Chen J, Chen
H, Zhang X and Liu Z: Detection of cytokeratin 20 mRNA in the
peripheral blood of patients with colorectal cancer by
immunomagnetic bead enrichment and real-time reverse
transcriptase-polymerase chain reaction. J Gastroenterol Hepatol.
20:1279–1284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayes DC, Secrist H, Bangur CS, Wang T,
Zhang X, Harlan D, Goodman GE, Houghton RL, Persing DH and
Zehentner BK: Multigene real-time PCR detection of circulating
tumor cells in peripheral blood of lung cancer patients. Anticancer
Res. 26:1567–1575. 2006.PubMed/NCBI
|
|
16
|
Gervasoni A, Monasterio Muñoz RM, Wengler
GS, Rizzi A, Zaniboni A and Parolini O: Molecular signature
detection of circulating tumor cells using a panel of selected
genes. Cancer Lett. 263:267–279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Song P, Zou B, Liu M, Cui K, Zhou P,
Li S and Zhang B: Circulating tumor cell analyses in patients with
esophageal squamous cell carcinoma using epithelial
marker-dependent and -independent approaches. Medicine (Baltimore).
94:e15652015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaganoi J, Shimada Y, Kano M, Okumura T,
Watanabe G and Imamura M: Detection of circulating oesophageal
squamous cancer cells in peripheral blood and its impact on
prognosis. Br J Surg. 91:1055–1060. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsushita D, Uenosono Y, Arigami T,
Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima
H, Kijima Y, et al: Clinical significance of circulating tumor
cells in peripheral blood of patients with esophageal squamous cell
carcinoma. Ann Surg Oncol. 22:3674–3680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McKeown KC: Total three-stage
oesophagectomy for cancer of the oesophagus. Br J Surg. 63:259–262.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lewis I: The surgical treatment of
carcinoma of the oesophagus; with special reference to a new
operation for growths of the middle third. Br J Surg. 34:18–31.
1946. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jian-Hui C, Shi-Rong C, Hui W, Si-le C,
Jian-Bo X, Er-Tao Z, Chuang-Qi C and Yu-Long H: Prognostic value of
three different lymph node staging systems in the survival of
patients with gastric cancer following D2 lymphadenectomy. Tumor
Biol. 37:11105–11113. 2016. View Article : Google Scholar
|
|
23
|
Cao J, Yuan P, Ma H, Ye P, Wang Y, Yuan X,
Bao F, Lv W and Hu J: Log odds of positive lymph nodes predicts
survival in patients after resection for esophageal cancer. Ann
Thorac Surg. 102:424–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Jiang M, Zhao J and Ju H:
Circulating tumor cells in perioperative esophageal cancer
patients: Quantitative assay system and potential clinical utility.
Clin Cancer Res. 13:2992–2997. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pelkey TJ, Frierson HF Jr and Bruns DE:
Molecular and immunological detection of circulating tumor cells
and micrometastases from solid tumors. Clin Chem. 42:1369–1381.
1996.PubMed/NCBI
|
|
26
|
Hofman VJ, Ilie MI, Bonnetaud C, Selva E,
Long E, Molina T, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, et
al: Cytopathologic detection of circulating tumor cells using the
isolation by size of epithelial tumor cell method. Am J Clin
Pathol. 135:146–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roxburgh CS and McMillan DC: Role of
systemic inflammatory response in predicting survival in patients
with primary operable cancer. Future Oncol. 6:149–163. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DeNardo DG, Johansson M and Coussens LM:
Immune cells as mediators of solid tumor metastasis. Cancer
Metastasis Rev. 27:11–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sharaiha RZ, Halazun KJ, Mirza F, Port JL,
Lee PC, Neugut AI, Altorki NK and Abrams JA: Elevated preoperative
neutrophil: Lymphocyte ratio as a predictor of postoperative
disease recurrence in esophageal cancer. Ann Surg Oncol.
18:3362–3369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiaolei W: Clinical study on the
prognostic value of pre_operative neutrophil lymphocyte ratio and
platelet lymphocyte ratio in patients of esophageal squamous cell
carcinomaJinan, Shandong University: 2013
|
|
32
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer;
New York, NY: 2010
|
|
33
|
Dutkowski P, Hommel G, Böttger T, Schlick
T and Junginger T: How many lymph nodes are needed for an accurate
pN classification in esophageal cancer? Evidence for a new
threshold value. Hepatogastroenterology. 49:176–180.
2002.PubMed/NCBI
|
|
34
|
Rizk NP, Ishwaran H, Rice TW, Chen LQ,
Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, et al:
Optimum lymphadenectomy for esophageal cancer. Ann Surg. 251:46–50.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schumacher D, Strilic B, Sivaraj KK,
Wettschureck N and Offermanns S: Platelet-derived nucleotides
promote tumor-cell transendothelial migration and metastasis via
P2Y2 receptor. Cancer Cell. 24:130–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Cheng X, Chen Z, Liu Y, Liu Z and Xu
S: Circulating tumor cells in peripheral and pulmonary venous blood
predict poor long-term survival in resected non-small cell lung
cancer patients. Sci Rep. 7:49712017. View Article : Google Scholar : PubMed/NCBI
|
